Can Adderall (amphetamine and dextroamphetamine) cause transaminitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adderall Can Cause Transaminitis

Yes, Adderall (amphetamine and dextroamphetamine) can cause transaminitis, with documented cases of acute liver injury occurring during treatment. 1

Mechanism and Risk

  • Adderall contains amphetamine compounds that can cause idiosyncratic drug-induced liver injury, similar to other medications that undergo hepatic metabolism 1
  • The risk appears to be higher in individuals with underlying liver conditions or previous liver surgery 1
  • Transaminitis from Adderall appears to be rare but can range from mild elevations to severe hepatotoxicity 1

Clinical Presentation

  • Patients may present with symptoms including abdominal pain, malaise, and jaundice 1
  • Laboratory findings typically show elevated liver enzymes (AST and ALT), which may be detected during routine monitoring 2
  • The pattern of liver injury is typically hepatocellular, characterized by predominantly elevated transaminases 3

Monitoring and Management

  • For patients on Adderall, monitoring liver function is prudent, especially in those with risk factors for liver disease 1

  • If transaminitis occurs:

    • For mild elevations (<3× upper limit of normal): continued monitoring may be appropriate 4
    • For significant elevations (>3× upper limit of normal): consideration should be given to discontinuing Adderall 4
    • For severe hepatotoxicity (AST or ALT >5× ULN): immediate discontinuation is recommended 4
  • After discontinuation, liver enzymes should be monitored until normalization 4

  • Recovery typically occurs with conservative management and discontinuation of the medication 1

Differential Diagnosis

  • When transaminitis is detected in a patient taking Adderall, other common causes should be evaluated: 2

    • Nonalcoholic fatty liver disease
    • Alcoholic liver disease
    • Other drug-induced liver injury
    • Viral hepatitis
    • Metabolic disorders
  • Initial evaluation should include: 2

    • Assessment for metabolic syndrome
    • Complete blood count with platelets
    • Serum albumin, iron studies
    • Hepatitis B and C testing

Special Considerations

  • Patients with a history of liver disease or abnormal baseline liver function should use Adderall with caution 1
  • Similar to other medications that can cause idiosyncratic drug-induced liver injury, the risk of hepatotoxicity with Adderall may not be dose-dependent 3
  • The time course from initiation of Adderall to development of transaminitis can vary from days to months 1

Comparison to Other Medications

  • The risk of hepatotoxicity with Adderall appears to be lower than with some other classes of medications such as certain antibiotics 4
  • Other commonly prescribed medications that can cause transaminitis include certain antihypertensives 5 and beta-blockers 6

References

Research

Adderall induced acute liver injury: a rare case and review of the literature.

Case reports in gastrointestinal medicine, 2013

Research

Abnormal Liver Enzymes.

Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates, 2018

Guideline

Cefoperazone-Induced Transaminitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hepatotoxicity associated with carvedilol.

The Annals of pharmacotherapy, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.